281
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Non-adherence in difficult asthma and advances in detection

&
Pages 607-614 | Published online: 09 Jan 2014

References

  • Barnes PJ, Woolcock AJ. Difficult asthma. Eur. Respir. J. 12(5), 1209–1218 (1998).
  • Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am. J. Respir. Crit. Care Med. 162(6), 2341–2351 (2000).
  • Heaney LG, Conway E, Kelly C et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 58(7), 561–566 (2003).
  • Robinson DS, Campbell DA, Durham SR et al. Systematic assessment of difficult-to-treat asthma. Eur. Respir. J. 22(3), 478–483 (2003).
  • Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am. J. Respir. Crit. Care Med. 180(9), 817–822 (2009).
  • Horne R. Compliance, adherence and concordance: implications for asthma treatment. Chest 130(1 Suppl.), S65–S72 (2006).
  • Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann. Allergy Asthma. Immunol. 79(3), 177–185, quiz 185–186 (1997).
  • Murphy AC, Proeschal A, Brightling CE et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 67(8), 751–753 (2012).
  • Bracken M, Fleming L, Hall P et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch. Dis. Child 94(10), 780–784 (2009).
  • Lasmar L, Camargos P, Champs NS et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 64(5), 784–789 (2009).
  • Jentzsch NS, Camargos P, Sarinho ES, Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir. Med. 106(3), 338–343 (2012).
  • Koster ES, Raaijmakers JA, Vijverberg SJ, Maitland-van der Zee AH. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study. Pharmacoepidemiol. Drug Saf. 20(10), 1064–1072 (2011).
  • Pizzichini MM, Pizzichini E, Clelland L et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur. Respir. J. 13(1), 15–21 (1999).
  • Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360(9347), 1715–1721 (2002).
  • Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am. J. Respir. Crit. Care Med. 164(8 Pt 1), 1376–1381 (2001).
  • Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 57(10), 889–896 (2002).
  • Dweik RA, Boggs PB, Erzurum SC et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 184(5), 602–615 (2011).
  • Smith AD, Cowan JO, Brassett KP et al. Exhaled nitric oxide: a predictor of steroid response. Am. J. Respir. Crit. Care Med. 172(4), 453–459 (2005).
  • van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54(5), 403–408 (1999).
  • Haahtela T, Jarvinen M, Kava T et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331(11), 700–705 (1994).
  • Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 57(10), 880–884 (2002).
  • Williams LK, Peterson EL, Wells K et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J. Allergy Clin. Immunol. 128(6), 1185–1191 e2 (2011).
  • Stempel DA, Roberts CS, Stanford RH. Treatment patterns in the months prior to and after asthma-related emergency department visit. Chest 126(1), 75–80 (2004).
  • Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N. Engl. J. Med. 343(5), 332–336 (2000).
  • ONeill C, Gamble J, Lindsay JT, Heaney LG. The Impact of Nonadherence to Inhaled Long-Acting 2-Adrenoceptor AgonistCorticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma. Pharm. Med. 25(6), 379–385 (2011).
  • Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr. Opin. Allergy Clin. Immunol. 4(3), 191–195 (2004).
  • Tan H, Sarawate C, Singer J et al. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes. Mayo Clin. Proc. 84(8), 675–684 (2009).
  • Pavord ID, Korn S, Howarth P et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380(9842), 651–659 (2012).
  • Gillespie R. Manufacturing Knowledge: A History of the Hawthorne Experiments. Cambridge University Press, Cambridge, UK (1991).
  • Braunstein GL, Trinquet G, Harper AE. Compliance with nedocromil sodium and a nedocromil sodium/salbutamol combination. Compliance Working Group. Eur. Respir. J. 9(5), 893–898 (1996).
  • Berg J, Dunbar-Jacob J, Sereika SM. An evaluation of a self-management program for adults with asthma. Clin. Nurs. Res. 6(3), 225–238 (1997).
  • Coutts JA, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch. Dis. Child. 67(3), 332–333 (1992).
  • Reznik M, Ozuah PO. Measurement of inhaled corticosteroid adherence in inner-city, minority children with persistent asthma by parental report and integrated dose counter. J. Allergy (Cairo). 2012, 570850 (2012).
  • Krishnan JA, Bender BG, Wamboldt FS et al. Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J. Allergy Clin. Immunol. 129(1), 112–118 (2012).
  • Bender B, Wamboldt FS, O’Connor SL et al. Measurement of children’s asthma medication adherence by self-report, mother report, canister weight, and Doser CT. Ann. Allergy Asthma Immunol. 85(5), 416–421 (2000).
  • Cohen JL, Mann DM, Wisnivesky JP et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma. Ann. Allergy Asthma Immunol. 103(4), 325–331 (2009).
  • Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long-term clinical trial. Arch. Dis. Child 83(4), 330–333 (2000).
  • McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma. Am. J. Respir. Crit. Care Med. 186(11), 1102–1108 (2012).
  • Rand CS, Wise RA, Nides M et al. Metered-dose inhaler adherence in a clinical trial. Am. Rev. Respir. Dis. 146(6), 1559–1564 (1992).
  • Krishnan JA, Riekert KA, McCoy JV et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am. J. Respir. Crit. Care Med. 170(12), 1281–1285 (2004).
  • LaForce C, Weinstein C, Nathan RA, Weinstein SF, Staudinger H, Meltzer EO. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J. Asthma 48(6), 625–631 (2011).
  • Chung KF, Naya I. Compliance with an oral asthma medication: a pilot study using an electronic monitoring device. Respir. Med. 94(9), 852–858 (2000).
  • Apter AJ, Wang X, Bogen DK et al. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: a randomized controlled trial. J. Allergy Clin. Immunol. 128(3), 516–523 e1–5 (2011).
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (2), CD000011 (2008).
  • Onyirimba F, Apter A, Reisine S et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann. Allergy Asthma Immunol. 90(4), 411–415 (2003).
  • Gamble J, Stevenson M, Heaney LG. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir. Med. 105(9), 1308–1315 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.